Auto giants rally as China says it will consider exemptions for Nexperia chip exports

Auto giants rally as China says it will consider exemptions for Nexperia chip exports


In this photo illustration, the logo of semiconductor manufacturer Nexperia is displayed on a screen.

Vcg | Visual China Group | Getty Images

Shares of Europe’s biggest carmakers rose on Monday as fears over an industry shortage of semiconductors appeared to recede.

China on Saturday said it would consider some exemptions for Nexperia chip exports. It had previously blocked Nexperia semiconductors from leaving the country after the Dutch government seized control of Nexperia, owned by the Chinese company Wingtech.

The standoff between the Netherlands and China had prompted automotive groups to raise the alarm over a worsening chip shortage.

France’s Renault, Germany’s Mercedes-Benz Group and Milan-listed shares of Jeep-maker Stellantis were all trading up around 3% on Monday morning.

Auto parts suppliers Valeo and Aumovio had advanced 3% and 1.6%, respectively, by around 11:30 a.m. London time (6:30 a.m. ET).

Germany’s Volkswagen, Porsche and BMW were also trading more than 1.3% higher.

Stock Chart IconStock chart icon

hide content

Shares of Volkswagen over the last three months compared to other major European automakers.

Analysts at Barclays said developments over the weekend appeared to be “quite positive” for the automotive sector, with fears of significant disruption likely to be avoided.

“While the Nexperia issue is not fully resolved, with ongoing negotiations between the Dutch and Chinese government to determine a path forward for Nexperia, we believe the potential near-term production headwind has been remediated, although we await more details,” Dan Levy, senior autos analyst at Barclays, said in a research note published Monday.

The situation involving Nexperia began in September, when the Dutch government took control of the company, in what was seen as a highly unusual move, reportedly after the U.S. raised security concerns.

In making the decision, the Dutch government cited fears that tech from the company — which specializes in the high-volume production of chips used in automotive, consumer electronics and other industries — “would become unavailable in an emergency.”

China responded by blocking exports of the firm’s finished products.

German automakers are thought to be especially sensitive to Nexperia-related disruptions because they rely heavily on large, domestic suppliers, known as “Tier 1s,” and local production facilities and companies, such as Nexperia, despite much of its manufacturing moving to China.

Japan’s Honda Motor became the first known automaker to reduce production due to the problem last week.



Source

Tesla faces widening federal probe into door handle safety issues
World

Tesla faces widening federal probe into door handle safety issues

Tesla models Y and 3 are displayed at a Tesla showroom in Corte Madera, California, on Dec. 20, 2024. Justin Sullivan | Getty Images Tesla has been ordered to provide records to U.S. federal auto safety regulators to comply with a sweeping investigation into possible safety defects with the company’s flush-mounted, retractable door handles that […]

Read More
Russia looks to cosy up with China after Trump’s meeting with Xi
World

Russia looks to cosy up with China after Trump’s meeting with Xi

In this pool photograph distributed by the Russian state agency Sputnik, Russian Prime Minister Mikhail Mishustin (R) arrives at the airport of Hangzhou on November 3, 2025. Dmitry Astakhov | Afp | Getty Images Russian officials appeared eager Monday to reaffiirm Moscow’s alliance with China following U.S. President Donald Trump’s high-profile meeting with Xi Jinping. […]

Read More
Kimberly-Clark to buy Kenvue in .7 billion deal
World

Kimberly-Clark to buy Kenvue in $48.7 billion deal

The company logo for Kenvue Inc. Johnson & Johnson’s consumer-health business is displayed during the company’s initial public offering at the New York Stock Exchange on May 4, 2023. Brendan Mcdermid | Reuters Kimberly-Clark said on Monday it will buy Tylenol-maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, to create one of […]

Read More